Ph.D., CSO
Didier Roche is co-founder and Chief Scientific Officer at Edelris. Didier has been working 13 years in the pharmaceutical industry at Novartis and Merck KGaA where he led a group of 25 chemists for the diabetes division and contributed to the clinical development of 3 drug candidates.
Didier holds a Ph.D. from Louis Pasteur University in Strasbourg and achieved his post-doctoral training in Central Research at Ciba-Geigy. He has co-authored over 50 publications and patents.
“At Edelris, we strongly believe that innovation starts in the design of the molecules used for the screening of biological targets. Our commitment is to deliver high quality hits to our clients and accelerate the phases leading to the selection of drug candidates”